Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity

v3.22.1
Condensed Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Global Medical REIT Inc. [Member]
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Global Medial REIT Inc. Stockholders' Equity [Member]
Noncontrolling Interest [Member]
Total
Balances at Dec. 31, 2020 $ 444,805 $ 49 $ 74,959 $ 504,789 $ (116,773) $ (18,219)   $ 12,955 $ 457,760
Balance (in shares) at Dec. 31, 2020   49,461 3,105            
Net income 3,211       3,211     112 3,323
Issuance of shares of common stock, net 144,172 $ 12   144,160         144,172
Issuance of shares of common stock, net (in shares)   11,333              
Change in fair value of interest rate swap agreements 3,631         3,631     3,631
Stock-based compensation expense               1,715 1,715
Dividends to common stockholders (12,463)       (12,463)       (12,463)
Dividends to preferred stockholders (1,455)       (1,455)       (1,455)
Dividends to noncontrolling interest               (864) (864)
Balances at Mar. 31, 2021 $ 581,901 $ 61 $ 74,959 648,949 (127,480) (14,588)   13,918 595,819
Balances (in shares) at Mar. 31, 2021   60,794 3,105            
Balances at Dec. 31, 2021   $ 65 $ 74,959 711,414 (157,017) (6,636) $ 622,785 14,792 637,577
Balance (in shares) at Dec. 31, 2021   64,880 3,105            
Net income         4,116   4,116 170 4,286
Issuance of shares of common stock, net       8,210     8,210   8,210
Issuance of shares of common stock, net (in shares)   480              
LTIP Units and OP Units redeemed for common stock       682     682 (682)  
LTIP Units and OP Units redeemed for common stock (in shares)   40              
Change in fair value of interest rate swap agreements           17,393 17,393   17,393
Stock-based compensation expense               1,287 1,287
Dividends to common stockholders         (13,733)   (13,733)   (13,733)
Dividends to preferred stockholders         (1,455)   (1,455)   (1,455)
Dividends to noncontrolling interest               (948) (948)
Balances at Mar. 31, 2022   $ 65 $ 74,959 $ 720,306 $ (168,089) $ 10,757 $ 637,998 $ 14,619 $ 652,617
Balances (in shares) at Mar. 31, 2022   65,400 3,105